News
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...
2don MSN
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...
When you buy through links on our articles, Future and its syndication partners may earn a commission.
The FDA’s new framework for COVID-19 vaccines breaks from established procedure for how the government establishes vaccine ...
The US Food and Drug Administration may limit Covid-19 boosters shots to high-risk groups from 2025; Pfizer reviewing proposal as agency seeks new trials, clearer risk labels for younger males ...
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be ...
The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to receive booster shots. FDA officials are asking for more data around the ...
The agency said it would approve new versions of the vaccine only for adults 65 years of age and older as well as for people with one or more risk factors for severe COVID-19 outcomes. These risk ...
The Trump administration announced Tuesday that going forward, COVID-19 vaccines would be FDA-approved only for people over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results